Cargando…
Glomerular Hyperfiltration and Renal Disease Progression in Type 2 Diabetes
OBJECTIVE: To describe the prevalence and determinants of hyperfiltration (glomerular filtration rate [GFR] ≥120 mL/min/1.73 m(2)), GFR decline, and nephropathy onset or progression in type 2 diabetic patients with normo- or microalbuminuria. RESEARCH DESIGN AND METHODS: We longitudinally studied 60...
Autores principales: | Ruggenenti, Piero, Porrini, Esteban L., Gaspari, Flavio, Motterlini, Nicola, Cannata, Antonio, Carrara, Fabiola, Cella, Claudia, Ferrari, Silvia, Stucchi, Nadia, Parvanova, Aneliya, Iliev, Ilian, Dodesini, Alessandro Roberto, Trevisan, Roberto, Bossi, Antonio, Zaletel, Jelka, Remuzzi, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3447826/ https://www.ncbi.nlm.nih.gov/pubmed/22773704 http://dx.doi.org/10.2337/dc11-2189 |
Ejemplares similares
-
Impact of a Complement Factor H Gene Variant on Renal Dysfunction, Cardiovascular Events, and Response to ACE Inhibitor Therapy in Type 2 Diabetes
por: Valoti, Elisabetta, et al.
Publicado: (2019) -
Preventing Left Ventricular Hypertrophy by ACE Inhibition in Hypertensive Patients With Type 2 Diabetes: A prespecified analysis of the Bergamo Nephrologic Diabetes Complications Trial (BENEDICT)
por: Ruggenenti, Piero, et al.
Publicado: (2008) -
Effects of Combined Ezetimibe and Simvastatin Therapy as Compared With Simvastatin Alone in Patients With Type 2 Diabetes: A prospective randomized double-blind clinical trial
por: Ruggenenti, Piero, et al.
Publicado: (2010) -
ADAMTS13 Predicts Renal and Cardiovascular Events in Type 2 Diabetic Patients and Response to Therapy
por: Rurali, Erica, et al.
Publicado: (2013) -
Preventing microalbuminuria with benazepril, valsartan, and benazepril–valsartan combination therapy in diabetic patients with high-normal albuminuria: A prospective, randomized, open-label, blinded endpoint (PROBE) study
por: Ruggenenti, Piero, et al.
Publicado: (2021)